Infusion pumps recalled under FDA agreement
Baxter International, a manufacturer of medical infusion pumps has recalled its Colleague model of pumps from the American marker due to battery failures and software errors.
In late April, the Food and Drug Administration announced that the infusion pumps, which are used to administer drugs and other liquids to patients, were linked to more than 56,000 deaths and injuries from 2005-2009. The Baxter Healthcare Corporation, a subsidiary of Baxter International, is under a consent decree with the federal regulator which allows the agency to require a recall.
Baxter asserts there are less than 200,000 Colleague pumps in use and no new pumps have been sold since 2005. No new pumps of the Colleague model will be sold and they plan to offer an exchange with a Sigma Spectrum infusion pump.
The infusion pumps, which are used to administer drugs such as chemotherapy to cancer patients have been linked to deaths due to overdose when the software malfunctions. The pumps are used at hospitals and by patients at home.